Loading...

KIT in Melanoma: Many Shades of Gray

Activating mutations in KIT have been identified in melanomas of acral and mucosal types and in those arising in chronically sun-damaged skin. Until now, KIT has been considered an oncogenic driver and a potential therapeutic target. However, data presented by Dhal et al. show that in cutaneous mela...

Full description

Saved in:
Bibliographic Details
Published in:J Invest Dermatol
Main Authors: Slipicevic, Ana, Herlyn, Meenhard
Format: Artigo
Language:Inglês
Published: 2015
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4669950/
https://ncbi.nlm.nih.gov/pubmed/25573046
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/jid.2014.417
Tags: Add Tag
No Tags, Be the first to tag this record!